HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Primary vitrectomy for the treatment of retinal detachment in highly myopic eyes with axial length over 30 mm.

AbstractOBJECTIVE:
To assess the functional and anatomical outcome of primary vitrectomy without scleral buckling for rhegmatogenous retinal detachment (RRD) in highly myopic eyes with axial length over 30 mm.
METHODS:
In this retrospective, interventional case series, we evaluated the outcome of primary vitrectomy without scleral buckling in 67 highly myopic patients (67 eyes) with RRD. Anatomical success rate was defined as complete reattachment of the retina without definitive silicone oil tamponade.
RESULTS:
Retinal reattachment was achieved with a single surgery in 49 of 67 eyes (73.1%) and after 2 or 3 surgeries in 54 eyes (80.6%). The characteristics of retinal tears did not influence the final outcome. Multivariate analysis revealed that a longer axial length was the only factor associated with a higher failure rate, p = 0.0061. Mean preoperative visual acuity significantly increased after surgery, p = 0.0003.
CONCLUSION:
The study demonstrated fair efficacy of vitrectomy and fluid-gas exchange in the treatment of retinal detachment in highly myopic eyes with an axial length over 30 mm.
AuthorsBrice Dugas, Alain M Bron, Grégoire Minoyan, Serge Aho, Jean Paul Berrod, Catherine P Creuzot-Garcher
JournalEuropean journal of ophthalmology (Eur J Ophthalmol) 2013 Jul-Aug Vol. 23 Issue 4 Pg. 564-70 ISSN: 1724-6016 [Electronic] United States
PMID23539456 (Publication Type: Journal Article)
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Axial Length, Eye (pathology)
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Myopia (complications, pathology)
  • Retinal Detachment (etiology, surgery)
  • Retrospective Studies
  • Visual Acuity
  • Vitrectomy (methods)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: